AA
ITCI

AQR Arbitrage’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

AQR Arbitrage’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-252,316
Closed -$33.3M – 489
2025
Q1 		$33.3M Buy
+252,316
New +$31.4M 0.79% 38

Other funds holding ITCI

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
KIM
Kestra Investment Management Austin, Texas $5.8B AUM 14.71% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

AQR Arbitrage's ITCI Position: Q2 2025 in Review

AQR Arbitrage sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 252,316 shares — an estimated $33.3M sold.

AQR Arbitrage first reported a position in ITCI in Q1 2025 and held it in 1 quarter. The position peaked at $33.3M in Q1 2025. 4 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.

  • AQR Arbitrage reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
  • AQR Arbitrage sold 252,316 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $33.3M.
  • AQR Arbitrage first reported a position in Intra-Cellular Therapies Inc. in Q1 2025 and held it in 1 quarter.
  • AQR Arbitrage's Intra-Cellular Therapies Inc. position peaked at $33.3M in Q1 2025.
  • 4 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.

Based on AQR Arbitrage's 13F filing for Q2 2025, filed 14 Aug 2025.